Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Parkinson Disease/complications/drug therapy"'
Autor:
Paul Krack, Anna Castrioto, Roshan Cools, Aurélie Funkiewiez, Claire Ardouin, Trevor W. Robbins, Bettina Debû, Stephan Chabardes, Pierre Pollak, Valérie Fraix, Eugénie Lhommée
Publikováno v:
Journal of Neurology, Neurosurgery, and Psychiatry, Vol. 86, No 2 (2015) pp. 186-190
Journal of Neurology, Neurosurgery, and Psychiatry, 86, 186-90
Journal of Neurology, Neurosurgery, and Psychiatry, 86, 2, pp. 186-90
Journal of Neurology, Neurosurgery, and Psychiatry, 86, 186-90
Journal of Neurology, Neurosurgery, and Psychiatry, 86, 2, pp. 186-90
Item does not contain fulltext BACKGROUND: Impulse control disorders (ICD), including pathological gambling, are common in Parkinson's disease (PD) and tend to improve after subthalamic (STN) stimulation after a marked reduction of dopaminergic medic
Autor:
Jean-Louis Quesada, Pierre Pollak, Emmanuelle Schmitt, Paul Krack, Anna Castrioto, Patrick Mertens, Emmanuel Broussolle, Valérie Fraix, Stephan Chabardes, Eugénie Lhommée, Hélène Klinger, Stéphane Thobois, Andrea Kistner
Publikováno v:
Journal of Neurology, Neurosurgery, and Psychiatry, Vol. 84, No 1 (2013) pp. 18-22
Background Levodopa therapy in Parkinson9s disease (PD) is associated with non-motor complications resulting from sensitisation of the ventral striatum system. Recent studies showed an improvement in non-motor complications in PD patients with subtha
Publikováno v:
European Journal of Neurology, Vol. 14, No 10 (2007) pp. 1124-8
Levodopa (LD)-induced dyskinesia (LID), one of the most common motor complications in advanced Parkinson's disease (PD), involve mostly the limbs, trunk and head, but unusual locations have been reported including respiratory muscles, the face and th
Autor:
Vanessa Fleury, Alice Poisson, Claire Ardouin, Pierre Pollak, Jing Xie, M. Aya Kombo, Emmanuel Broussolle, Christelle Lagrange, Andrea Kistner, Eugénie Lhommée, Hélène Klinger, Stéphane Thobois, Valérie Fraix, Paul Krack, Emmanuelle Schmitt
Publikováno v:
Revue neurologique, Vol. 166, No 10 (2010) pp. 816-821
Resume Introduction Les troubles psychiques de la maladie de Parkinson peuvent etre classes dans deux categories opposees : hypodopaminergiques s’ils sont lies a la denervation dopaminergique et hyperdopaminergiques s’ils sont en rapport avec le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c50cdf70c815746f27e78be3fd67405c
https://archive-ouverte.unige.ch/unige:93624
https://archive-ouverte.unige.ch/unige:93624
Autor:
Alexander Reuss, Carmen Schade-Brittinger, Helmut Schäfer, Jan Herzog, Ulrich Steude, Volker M. Tronnier, Volker Sturm, Jens Volkmann, Angela Deutschländer, Lars Wojtecki, Wilhelm Eisner, Martin Krause, C. Daniels, Stephan Klebe, Ulrich Dillmann, Andreas Kupsch, Alfons Schnitzler, Doreen Gruber, Jean Richard Moringlane, Jürgen Voges, Gerd-Helge Schneider, Rüdiger Hilker, Günther Deuschl, Delia Lorenz, Werner Poewe, Thomas Trottenberg, Stefan Lorenzl, J. Koy, Wolfgang Hamel, Manja Kloss, H. Maximilian Mehdorn, Marcus O. Pinsker, Paul Krack, Lars Timmermann, Heinz Reichmann, Elisabeth Wolf, Kai Bötzel, Wolfgang H. Oertel
Publikováno v:
New England Journal of Medicine
New England Journal of Medicine, Massachusetts Medical Society, 2006, 355 (9), pp.896-908. ⟨10.1056/NEJMoa060281⟩
New England Journal of Medicine, Vol. 355, No 9 (2006) pp. 896-908
New England Journal of Medicine, 2006, 355 (9), pp.896-908. ⟨10.1056/NEJMoa060281⟩
New England Journal of Medicine, Massachusetts Medical Society, 2006, 355 (9), pp.896-908. ⟨10.1056/NEJMoa060281⟩
New England Journal of Medicine, Vol. 355, No 9 (2006) pp. 896-908
New England Journal of Medicine, 2006, 355 (9), pp.896-908. ⟨10.1056/NEJMoa060281⟩
International audience; BACKGROUND: Neurostimulation of the subthalamic nucleus reduces levodopa-related motor complications in advanced Parkinson's disease. We compared this treatment plus medication with medical management. METHODS: In this randomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37fe0f407ffbac19b074ae29d3f3d77b
https://www.hal.inserm.fr/inserm-00391622
https://www.hal.inserm.fr/inserm-00391622
Publikováno v:
Scopus-Elsevier
Neurology, Vol. 64, No 2 (2005) pp. 392-3
Neurology, Vol. 64, No 2 (2005) pp. 392-3
Subcutaneous intermittent injections or continuous infusions of apomorphine have been used successfully in the treatment of advanced Parkinson disease (PD) for more than two decades.1,2 Subcutaneous nodules at the infusion sites are frequent but rare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed7efe651daf44c10d7e48fba13e87fc
http://www.scopus.com/inward/record.url?eid=2-s2.0-12544255437&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-12544255437&partnerID=MN8TOARS